US Stock MarketDetailed Quotes

Sionna Therapeutics (SION)

Watchlist
  • 43.120
  • +2.180+5.32%
Close May 13 16:00 ET
  • 43.120
  • 0.0000.00%
Post 16:10 ET
1.95BMarket Cap-22.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sionna Therapeutics (SION) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
50.56%29.6M
26.12%88.98M
30.22%23.61M
-14.93%23.81M
94.00%21.91M
49.53%19.66M
40.18%70.56M
43.97%18.13M
27.98M
11.29M
Selling and administrative expenses
82.52%10.15M
116.45%28.72M
96.52%9.87M
140.25%7.24M
126.49%6.05M
117.10%5.56M
36.68%13.27M
85.73%5.02M
--3.01M
--2.67M
-General and administrative expense
82.52%10.15M
116.45%28.72M
96.52%9.87M
140.25%7.24M
126.49%6.05M
117.10%5.56M
36.68%13.27M
85.73%5.02M
--3.01M
--2.67M
Research and development costs
38.74%18.96M
5.19%60.26M
6.42%15.17M
-34.73%16.04M
86.85%15.38M
33.74%13.67M
41.01%57.29M
44.12%14.25M
--24.58M
--8.23M
Depreciation amortization depletion
13.23%488K
----
----
34.02%520K
22.56%478K
17.76%431K
----
----
--388K
--390K
-Depreciation and amortization
13.23%488K
----
----
34.02%520K
22.56%478K
17.76%431K
----
----
--388K
--390K
Operating profit
-50.56%-29.6M
-26.12%-88.98M
-30.22%-23.61M
14.93%-23.81M
-94.00%-21.91M
-49.53%-19.66M
-40.18%-70.56M
-43.97%-18.13M
-27.98M
-11.29M
Net non-operating interest income expense
-6.00%2.82M
62.73%13.3M
49.69%3.17M
46.88%3.46M
42.91%3.67M
165.02%3M
195.05%8.17M
283.18%2.12M
2.35M
2.57M
Non-operating interest income
-6.00%2.82M
62.73%13.3M
49.69%3.17M
46.88%3.46M
42.91%3.67M
165.02%3M
195.05%8.17M
283.18%2.12M
--2.35M
--2.57M
Other net income (expense)
-39.97%419K
0
-62.63%71K
-1.72%171K
5.36%177K
131.89%698K
0.00%166K
190K
174K
Other non- operating income (expenses)
----
-39.97%419K
--0
-62.63%71K
-1.72%171K
5.36%177K
131.89%698K
0.00%166K
--190K
--174K
Income before tax
-62.47%-26.78M
-22.01%-75.27M
-28.98%-20.44M
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
Income tax
Net income
-62.47%-26.78M
-22.01%-75.27M
-28.98%-20.44M
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
Net income continuous Operations
-62.47%-26.78M
-22.01%-75.27M
-28.98%-20.44M
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
---25.44M
---8.55M
Minority interest income
Net income attributable to the parent company
-62.47%-26.78M
-22.01%-75.27M
-28.98%-20.44M
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-62.47%-26.78M
-22.01%-75.27M
-28.98%-20.44M
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
Basic earnings per share
3.23%-0.6
-29.35%-1.88
-23.20%-0.46
23.26%-0.46
-103.49%-0.41
-45.47%-0.62
14.52%-1.4534
12.61%-0.3734
-0.5994
-0.2015
Diluted earnings per share
3.23%-0.6
-29.35%-1.88
-23.20%-0.46
23.26%-0.46
-103.49%-0.41
-45.47%-0.62
14.52%-1.4534
12.61%-0.3734
-0.5994
-0.2015
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 50.56%29.6M26.12%88.98M30.22%23.61M-14.93%23.81M94.00%21.91M49.53%19.66M40.18%70.56M43.97%18.13M27.98M11.29M
Selling and administrative expenses 82.52%10.15M116.45%28.72M96.52%9.87M140.25%7.24M126.49%6.05M117.10%5.56M36.68%13.27M85.73%5.02M--3.01M--2.67M
-General and administrative expense 82.52%10.15M116.45%28.72M96.52%9.87M140.25%7.24M126.49%6.05M117.10%5.56M36.68%13.27M85.73%5.02M--3.01M--2.67M
Research and development costs 38.74%18.96M5.19%60.26M6.42%15.17M-34.73%16.04M86.85%15.38M33.74%13.67M41.01%57.29M44.12%14.25M--24.58M--8.23M
Depreciation amortization depletion 13.23%488K--------34.02%520K22.56%478K17.76%431K----------388K--390K
-Depreciation and amortization 13.23%488K--------34.02%520K22.56%478K17.76%431K----------388K--390K
Operating profit -50.56%-29.6M-26.12%-88.98M-30.22%-23.61M14.93%-23.81M-94.00%-21.91M-49.53%-19.66M-40.18%-70.56M-43.97%-18.13M-27.98M-11.29M
Net non-operating interest income expense -6.00%2.82M62.73%13.3M49.69%3.17M46.88%3.46M42.91%3.67M165.02%3M195.05%8.17M283.18%2.12M2.35M2.57M
Non-operating interest income -6.00%2.82M62.73%13.3M49.69%3.17M46.88%3.46M42.91%3.67M165.02%3M195.05%8.17M283.18%2.12M--2.35M--2.57M
Other net income (expense) -39.97%419K0-62.63%71K-1.72%171K5.36%177K131.89%698K0.00%166K190K174K
Other non- operating income (expenses) -----39.97%419K--0-62.63%71K-1.72%171K5.36%177K131.89%698K0.00%166K--190K--174K
Income before tax -62.47%-26.78M-22.01%-75.27M-28.98%-20.44M20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M
Income tax
Net income -62.47%-26.78M-22.01%-75.27M-28.98%-20.44M20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M
Net income continuous Operations -62.47%-26.78M-22.01%-75.27M-28.98%-20.44M20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M---25.44M---8.55M
Minority interest income
Net income attributable to the parent company -62.47%-26.78M-22.01%-75.27M-28.98%-20.44M20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -62.47%-26.78M-22.01%-75.27M-28.98%-20.44M20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M
Basic earnings per share 3.23%-0.6-29.35%-1.88-23.20%-0.4623.26%-0.46-103.49%-0.41-45.47%-0.6214.52%-1.453412.61%-0.3734-0.5994-0.2015
Diluted earnings per share 3.23%-0.6-29.35%-1.88-23.20%-0.4623.26%-0.46-103.49%-0.41-45.47%-0.6214.52%-1.453412.61%-0.3734-0.5994-0.2015
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -